In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Animal Welfare Accountability and 
Transparency Act''.

SEC. 2. PUBLIC AVAILABILITY OF REGULATORY RECORDS.

    Notwithstanding any other provision of law, not later than 90 days 
after the date of enactment of this Act, the Secretary of Agriculture 
(referred to in this section as the ``Secretary'') shall maintain and 
promptly make available to the public in an online searchable database 
in a machine-readable format on the website of the Department of 
Agriculture information relating to the administration of the Animal 
Welfare Act (7 U.S.C. 2131 et seq.) and the Horse Protection Act (15 
U.S.C. 1821 et seq.), including--
            (1) the entirety of each report of any inspection 
        conducted, and record of any enforcement action taken, under--
                    (A) either of those Acts; or
                    (B) any regulation issued under those Acts;
            (2) with respect to the Animal Welfare Act--
                    (A) the entirety of each annual report submitted by 
                a research facility under section 13 of that Act (7 
                U.S.C. 2143); and
                    (B) the name, address, and license or registration 
                number of each research facility, exhibitor, dealer, 
                and other person or establishment--
                            (i) licensed by the Secretary under section 
                        3 or 12 of that Act (7 U.S.C. 2133, 2142); or
                            (ii) registered with the Secretary under 
                        section 6 of that Act (7 U.S.C. 2136); and
            (3) with respect to the Horse Protection Act, the name and 
        address of--
                    (A) any person that is licensed to conduct any 
                inspection under section 4(c) of that Act (15 U.S.C. 
                1823(c)); or
                    (B) any organization or association that is 
                licensed by the Department of Agriculture to promote 
                horses through--
                            (i) the showing, exhibiting, sale, auction, 
                        or registry of horses; or
                            (ii) the conduct of any activity that 
                        contributes to the advancement of horses.

SEC. 3. USE OF ALTERNATIVE DEPRECIATION SYSTEM FOR TAXPAYERS VIOLATING 
              CERTAIN ANIMAL PROTECTION RULES.

    (a) In General.--Section 168(g)(1) of the Internal Revenue Code of 
1986 is amended by striking ``and'' at the end of subparagraph (D), by 
inserting ``and'' at the end of subparagraph (E), and by inserting 
after subparagraph (E) the following new subparagraph:
                    ``(F) any property placed in service by a 
                disqualified taxpayer during an applicable period,''.
    (b) Definitions.--Section 168(g) of the Internal Revenue Code of 
1986 is amended by adding at the end the following new paragraph:
            ``(8) Disqualified taxpayer; applicable period.--For 
        purposes of paragraph (1)(F)--
                    ``(A) Disqualified taxpayer.--
                            ``(i) In general.--The term `disqualified 
                        taxpayer' means any taxpayer if such taxpayer--
                                    ``(I) has been assessed a civil 
                                penalty under section 19(b) of the 
                                Animal Welfare Act (7 U.S.C. 2149(b)) 
                                or section 6(b) of the Horse Protection 
                                Act (15 U.S.C. 1825(b)) and either the 
                                period for seeking judicial review of 
                                the final agency action has lapsed or 
                                there has been a final judgment with 
                                respect to an appeal of such 
                                assessment, or
                                    ``(II) has been convicted under 
                                section 19(d) of the Animal Welfare Act 
                                (7 U.S.C. 2149(d)) or section 6(a) of 
                                the Horse Protection Act (15 U.S.C. 
                                1825(a)) and there is a final judgment 
                                with respect to such conviction.
                            ``(ii) Aggregation rules.--All persons 
                        treated as a single employer under subsection 
                        (a) or (b) of section 52, or subsection (m) or 
                        (o) of section 414, shall be treated as one 
                        taxpayer for purposes of this subparagraph.
                    ``(B) Applicable period.--The term `applicable 
                period' means, with respect to any violation described 
                in subparagraph (A), the 5-taxable-year period 
                beginning with the taxable year in which the period for 
                seeking judicial review of a civil penalty described in 
                subparagraph (A)(i) has lapsed or in which there has 
                been a final judgment entered with respect to the 
                violation, whichever is earlier.''.
    (c) Conforming Amendment.--The last sentence of section 179(d)(1) 
is amended by inserting ``or any property placed in service by a 
disqualified taxpayer (as defined in section 168(g)(8)(A)) during an 
applicable period (as defined in section 168(g)(8)(B))'' after 
``section 50(b)''.
    (d) Effective Date.--The amendments made by this section shall 
apply to property placed in service in taxable years beginning after 
the date of the enactment of this section.

Output: Animal Welfare Accountability and Transparency Act  This bill requires the Department of Agriculture (USDA) to maintain and publicly disclose records relating to the administration of the Animal Welfare Act and the Horse Protection Act, including specified details regarding inspections, enforcement actions, regulations, registrations, and licenses under the two laws. Within 90 days of the enactment of this bill, USDA must make the records available to the public in an online searchable database in a machine-readable format on its website.  The bill also amends the Internal Revenue Code to require a taxpayer who has been convicted or assessed civil penalties for violating certain provisions of the Animal Welfare Act or the Horse Protection Act to use the alternative depreciation system that increases the number of years over which property is depreciated. The taxpayer must use the system for any property placed in service during the five-year period beginning with the year in which the period for seeking judicial review of a civil penalty has lapsed or in which there has been a final judgment entered with respect to the violation, whichever is earlier. 


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Right to Try Act''.

SEC. 2. USE OF UNAPPROVED MEDICAL PRODUCTS BY PATIENTS DIAGNOSED WITH A 
              TERMINAL ILLNESS.

    (a) In General.--Notwithstanding the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 301 et seq.), the Controlled Substances Act (21 
U.S.C. 801 et seq.), and any other provision of Federal law, the 
Federal Government shall not take any action to prohibit or restrict--
            (1) the production, manufacture, distribution, prescribing, 
        or dispensing of an experimental drug, biological product, or 
        device that--
                    (A) is intended to treat a patient who has been 
                diagnosed with a terminal illness; and
                    (B) is authorized by, and in accordance with, State 
                law; and
            (2) the possession or use of an experimental drug, 
        biological product, or device--
                    (A) that is described in subparagraphs (A) and (B) 
                of paragraph (1); and
                    (B) for which the patient has received a 
                certification from the patient's treating physician in 
                accordance with subsection (b).
    (b) Physician Certification.--A certification by the patient's 
treating physician referred to in subsection (a)(2)(B) must include 
each of the following:
            (1) A certification that the physician--
                    (A) is in good standing with the physician's 
                certifying organization or board; and
                    (B) has personally examined the patient.
            (2) A certification that there is no reason to conclude the 
        experimental drug, biological product, or device poses an 
        unreasonable and significant risk of danger to the patient.
            (3) A certification that the patient has been diagnosed 
        with a terminal disease or condition and does not have any 
        treatment options that--
                    (A) are comparable to treatment using the 
                experimental drug, biological product, or device or 
                otherwise satisfactory; and
                    (B) are approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) and are 
                available to diagnose, monitor, or treat the patient's 
                disease or condition.
            (4) A certification that the probable risk to the patient 
        from the experimental drug, biological product, or device is 
        not greater than the probable risk from the patient's disease 
        or condition.
            (5) A certification that the physician has provided the 
        patient with a written statement and oral explanation of the 
        medical treatment to be provided using the experimental drug, 
        biological product, or device.
            (6) An acknowledgement signed by the patient (or the 
        patient's legal representative) that the physician has provided 
        the written statement and oral explanation required by 
        paragraph (5), and has disclosed the following:
                    (A) That the medical treatment using the 
                experimental drug, biological product, or device is 
                experimental or nonconventional.
                    (B) That the experimental drug, biological product, 
                or device has not been approved, licensed, or cleared 
                for commercial distribution under section 505, 510(k), 
                or 515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) for any 
                indication.
                    (C) The material risks generally recognized by a 
                reasonably prudent physician of the medical treatment's 
                side effects.
                    (D) An explanation of the medical treatment, 
                including the expected frequency and duration of the 
                treatment.
    (c) No Liability or Use of Outcomes.--
            (1) No liability.--Notwithstanding any other provision of 
        law, no liability shall lie against a producer, manufacturer, 
        distributor, prescriber, dispenser, possessor, or user of an 
        experimental drug, biological product, or device for the 
        production, manufacture, distribution, prescribing, dispensing, 
        possession, or use of an experimental drug, biological product, 
        or device that is in compliance, with subsection (a).
            (2) No use of outcomes.--Notwithstanding any other 
        provision of law, the outcome of any production, manufacture, 
        distribution, prescribing, dispensing, possession, or use of an 
        experimental drug, biological product, or device that was done 
        in compliance with subsection (a) shall not be used by a 
        Federal agency reviewing the experimental drug, biological 
        product, or device to delay or otherwise adversely impact 
        review or approval of such experimental drug, biological 
        product, or device.
    (d) Rules of Construction.--Nothing in this Act shall be construed 
to--
            (1) require a manufacturer or other person to make 
        available any experimental drug, biological product, or device; 
        or
            (2) prohibit a manufacturer or other person from receiving 
        compensation or recovering costs for the production, 
        manufacture, distribution, or sale of an experiment drug, 
        biological product, or device.
    (e) Definitions.--In this section:
            (1) Biological product.--The term ``biological product'' 
        has the meaning given to such term in section 351 of the Public 
        Health Service Act (42 U.S.C. 262).
            (2) Device; drug.--The terms ``device'' and ``drug'' have 
        the meanings given to such terms in section 201 of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321).
            (3) Experimental drug, biological product, or device.--The 
        term ``experimental drug, biological product, or device'' means 
        a drug, biological product, or device that--
                    (A) has successfully completed a phase 1 clinical 
                investigation;
                    (B) remains under investigation in a clinical trial 
                approved by the Food and Drug Administration; and
                    (C) is not approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262).
            (4) Phase 1 clinical investigation.--The term ``phase 1 
        clinical investigation'' means a phase 1 clinical 
        investigation, as described in section 312.21 of title 21, Code 
        of Federal Regulations (or any successor regulations).
            (5) Terminal illness.--The term ``terminal illness'' has 
        the meaning given to such term in the State law specified in 
        subsection (a)(1)(B).

Output: Right to Try Act This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the treatment is experimental, and the patient, or the patient's legal representative, must acknowledge the explanation. A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment. The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment. The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale by the FDA.  


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sand Creek Massacre National 
Historic Site Trust Act of 2005''.

SEC. 2. DEFINITIONS.

    In this Act:
        (1) Facility.--The term ``facility'' means any structure, 
    utility, road, or sign constructed on the trust property on or 
    after the date of enactment of this Act.
        (2) Improvement.--The term ``improvement'' means--
            (A) a 1,625 square foot 1-story ranch house, built in 1952, 
        located in the SW quarter of sec. 30, T. 17 S., R. 45 W., sixth 
        principal meridian;
            (B) a 3,600 square foot metal-constructed shop building, 
        built in 1975, located in the SW quarter of sec. 30, T. 17 S., 
        R. 45 W., sixth principal meridian;
            (C) a livestock corral and shelter; and
            (D) a water system and wastewater system with all 
        associated utility connections.
        (3) Secretary.--The term ``Secretary'' means the Secretary of 
    the Interior.
        (4) Tribe.--The term ``Tribe'' means the Cheyenne and Arapaho 
    Tribes of Oklahoma, a federally recognized Indian tribe.
        (5) Trust property.--The term ``trust property'' means the real 
    property, including rights to all minerals, and excluding the 
    improvements, formerly known as the ``Dawson Ranch'', consisting of 
    approximately 1,465 total acres presently under the jurisdiction of 
    the Tribe, situated within Kiowa County, Colorado, and more 
    particularly described as follows:
            (A) The portion of sec. 24, T. 17 S., R. 46 W., sixth 
        principal meridian, that is the Eastern half of the NW quarter, 
        the SW quarter of the NE quarter, the NW quarter of the SE 
        quarter, sixth principal meridian.
            (B) All of sec. 25, T. 17 S., R. 46 W., sixth principal 
        meridian.
            (C) All of sec. 30, T. 17 S., R. 45 W., sixth principal 
        meridian.

SEC. 3. CONVEYANCE OF LAND TO BE HELD IN TRUST FOR THE CHEYENNE AND 
              ARAPAHO TRIBES OF OKLAHOMA.

    (a) Land Held in Trust for the Cheyenne and Arapaho Tribes of 
Oklahoma.--On conveyance of title to the trust property by the Tribe to 
the United States, without any further action by the Secretary, the 
trust property shall be held in trust for the benefit of the Tribe.
    (b) Trust.--All right, title, and interest of the United States in 
and to the trust property, except any facilities constructed under 
section 4(b), are declared to be held by the United States in trust for 
the Tribe.

SEC. 4. IMPROVEMENTS AND FACILITIES.

    (a) Improvements.--The Secretary may acquire by donation the 
improvements in fee.
    (b) Facilities.--
        (1) In general.--The Secretary may construct a facility on the 
    trust property only after consulting with, soliciting advice from, 
    and obtaining the agreement of, the Tribe, the Northern Cheyenne 
    Tribe, and the Northern Arapaho Tribe.
        (2) Ownership.--Facilities constructed with Federal funds or 
    funds donated to the United States shall be owned in fee by the 
    United States.
    (c) Federal Funds.--For the purposes of the construction, 
maintenance, or demolition of improvements or facilities, Federal funds 
shall be expended only on improvements or facilities that are owned in 
fee by the United States.

SEC. 5. SURVEY OF BOUNDARY LINE; PUBLICATION OF DESCRIPTION.

    (a) Survey of Boundary Line.--To accurately establish the boundary 
of the trust property, not later than 180 days after the date of 
enactment of this Act, the Secretary shall cause a survey to be 
conducted by the Office of Cadastral Survey of the Bureau of Land 
Management of the boundary lines described in section 2(5).
    (b) Publication of Land Description.--
        (1) In general.--On completion of the survey under subsection 
    (a), and acceptance of the survey by the representatives of the 
    Tribe, the Secretary shall cause the full metes and bounds 
    description of the lines, with a full and accurate description of 
    the trust property, to be published in the Federal Register.
        (2) Effect.--The description shall, on publication, constitute 
    the official description of the trust property.

SEC. 6. ADMINISTRATION OF TRUST PROPERTY.

    (a) In General.--The trust property shall be administered in 
perpetuity by the Secretary as part of the Sand Creek Massacre National 
Historic Site, only for historical, traditional, cultural, and other 
uses in accordance with the Sand Creek Massacre National Historic Site 
Establishment Act of 2000 (16 U.S.C. 461 note; Public Law 106-465).
    (b) Access for Administration.--For purposes of administration, the 
Secretary shall have access to the trust property, improvements, and 
facilities as necessary for management of the Sand Creek Massacre 
National Historic Site in accordance with the Sand Creek Massacre 
National Historic Site Establishment Act of 2000 (16 U.S.C. 461 note; 
Public Law 106-465).
    (c) Duty of the Secretary.--The Secretary shall take such action as 
is necessary to ensure that the trust property is used only in 
accordance with this section.
    (d) Savings Provision.--Nothing in this Act supersedes the laws and 
policies governing units of the National Park System.

SEC. 7. ACQUISITION OF PROPERTY.

    Section 6(a)(2) of the Sand Creek Massacre National Historic Site 
Establishment Act of 2000 (16 U.S.C. 461 note; Public Law 106-465) is 
amended by inserting ``or exchange'' after ``only by donation''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.


Output: Sand Creek Massacre National Historic Site Trust Act of 2005 - Authorizes the United States to take into trust specified real property formerly known as Dawson Ranch, including rights to all minerals and excluding improvements, in Kiowa County, Colorado, owned by the Cheyenne and Arapaho Indian Tribes of Oklahoma.

Directs the Tribes to convey title to the Dawson Ranch to the United States.

Declares that all right, title, and interest of the United States in and to the Ranch except any facilities constructed pursuant to this Act, are to be held in trust by the United States for the Tribes.

Authorizes the Secretary of the Interior to acquire by donation the improvements in fee. Permits the Secretary to construct a facility on the Ranch only after consulting with, soliciting advice from, and obtaining the agreement of, the Tribe, the Northern Cheyenne Tribe, and the Northern Arapaho Tribe. States that: (1) facilities constructed with federal funds or funds donated to the United States shall be owned in fee by the United States; and (2) for purposes of the construction, maintenance, or demolition of improvements or facilities, federal funds shall be expended only on improvements or facilities that are owned in fee by the United States.

Requires the Ranch to be administered in perpetuity by the Secretary as part of the Site only for historical, traditional, cultural, and other uses in accordance with the Sand Creek Massacre National Historic Site Establishment Act of 2000. Requires that, for purposes of administration, the Secretary shall have access to the Ranch, improvements, and facilities as necessary for the management of the Site in accordance with the Act. Instructs the Secretary to take such action as is necessary to ensure that the Ranch is used only in accordance with all such requirements for the administration of the Ranch.

Amends the Act to allow the Secretary to acquire land and interests in land within the boundaries of the Site which are owned by the state of Colorado (including a political subdivision of that state) only by donation or exchange (currently, only by donation).